Titlebook: High-Grade Gliomas; Diagnosis and Treatm Gene H. Barnett Book 2007 Humana Press 2007 Chemotherapie.brachytherapy.classification.glioma.imag

石墨

dysphagia

Alexander M. Spence,David A. Mankoff,Mark Muzi,Kristin Swanson

你敢命令

Michael P. Steinmetz,Jürgen Lüders,Edward C. Benzel

engrave

Imaging Tumor Biologybnormal metabolism; diffusion weighted imaging (DWI) as a measure of tumor cellularity, and the related technique of diffusion tensor imaging (DTI) as a measure of structural organization; and, imaging of tumor perfusion and vascular permeability, as a measure of vascularity and as an approach to the study of angiogenesis.

招惹

gentle

Computerized Tomographych facilitates sophisticated multiplanar three-dimensional (3D) imaging as well as dynamic imaging (i.e., CT-perfusion [CTP] and CT angiography [CTA]). These advanced techniques are extremely useful in preoperative localization, intraoperative navigation, and radiation therapy targeting.

沉積物

Nuclear Imaging of Gliomasherapy and chemotherapy, can now be regionally quantified in vivo with PET. In the near future it is likely that the presence of mutant receptors, apoptosis, and angiogenesis will also be measurable with PET and new tracers.

defendant

General Considerationslems and provide practical solutions for a physician looking after brain tumor patients. Issues regarding antiepileptic drug use, driving restrictions, steroids use, fatigue, blood clots, and alternative therapy will be reviewed in detail so that the care of the brain tumor patient can be improved.

脆弱帶來(lái)

2364-1134 s. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques an

outset

Histologic Classification of High-Grade Gliomase astrocytomas, oligodendrogliomas, mixed gliomas, and ependymomas. The histologic subtypes of glioblastoma multiforme and the affects of radiotherapy on gliomas will be discussed. The potential role for cell proliferation markers (Ki-67, MIB-1) in evaluating HGGs will be examined.